Neurobiology of addiction: a neurocircuitry analysis
- PMID: 27475769
- PMCID: PMC6135092
- DOI: 10.1016/S2215-0366(16)00104-8
Neurobiology of addiction: a neurocircuitry analysis
Abstract
Drug addiction represents a dramatic dysregulation of motivational circuits that is caused by a combination of exaggerated incentive salience and habit formation, reward deficits and stress surfeits, and compromised executive function in three stages. The rewarding effects of drugs of abuse, development of incentive salience, and development of drug-seeking habits in the binge/intoxication stage involve changes in dopamine and opioid peptides in the basal ganglia. The increases in negative emotional states and dysphoric and stress-like responses in the withdrawal/negative affect stage involve decreases in the function of the dopamine component of the reward system and recruitment of brain stress neurotransmitters, such as corticotropin-releasing factor and dynorphin, in the neurocircuitry of the extended amygdala. The craving and deficits in executive function in the so-called preoccupation/anticipation stage involve the dysregulation of key afferent projections from the prefrontal cortex and insula, including glutamate, to the basal ganglia and extended amygdala. Molecular genetic studies have identified transduction and transcription factors that act in neurocircuitry associated with the development and maintenance of addiction that might mediate initial vulnerability, maintenance, and relapse associated with addiction.
Copyright © 2016 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of interests
We declare no competing interests.
Figures


References
-
- American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th edn Washington DC: American Psychiatric Publishing, 2013.
-
- Koob GF, Le Moal M. Addiction and the brain antireward system. Annu Rev Psychol 2008; 59: 29–53. - PubMed
-
- McLellan AT, Lewis DC, O’Brien CP, Kleber HD. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA 2000; 284: 1689–95. - PubMed
-
- Koob GF, Le Moal M. Drug abuse: hedonic homeostatic dysregulation. Science 1997; 278: 52–58. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical